SCHEMBL9554143

SCHEMBL9554143

CCCCn1cc(CCC(C)C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c1=O

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 10/20 0.61
AGTR2 P50052 10/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9553859 0.97 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL9531801 0.95 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL9036019 0.93 AGTR1 (0.61) AGTR1AGTR2
SCHEMBL9554037 0.93 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9553714 0.92 AGTR1 (0.58) AGTR1AGTR2
Sc-51895 SCHEMBL6568041 0.92 AGTR1 (0.71) AGTR1AGTR2
SCHEMBL9036191 0.92 AGTR1 (0.66) AGTR1AGTR2
SCHEMBL9534462 0.92 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9530745 0.91 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9035149 0.91 AGTR1 (0.54) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed